Fundacja Onkologiczna AntyrakFoundation

Retail sale via mail order houses or via Internet

KRS: NIP:

Overview

Status
Active
Registry date
2018-08-21
Registered address
ul. Sowia 10, 86-005 Murowaniec, Poland
Electronic delivery address
AE:PL-98982-18973-RIVUS-24

Financials

Revenue history (in k)

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 37 days late).

  • 202501/07/2026
  • 202406/07/2025
  • 202315/06/2024
  • 202230/06/2023
  • 202121/08/2022
  • 202023/09/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 25.63kMedianUSD 89.11kAverageUSD 1.41m
Net profit
This companyUSD 8.22kMedianUSD 567.76AverageUSD 48.84k
Operating costs
This companyUSD 17.40kMedianUSD 87.59kAverageUSD 1.33m
Assets
This companyUSD 48.13kMedianUSD 47.38kAverageUSD 567.14k

Authorized Representatives

Ewa Jakielska – Management Board Member
Tomasz Janusz Horabik – Vice President of the Management Board
Magdalena Tauer Horabik – President of the Management Board

Manner of representation

Declarations of will on behalf of the foundation in all matters except property matters may be made by each member of the management board independently. 2. In property matters, the signatures of two members of the management board acting jointly, including the President, are required.

Supervisory board

Adam Andrzej Kajko – Supervisory Board Member
Bożena Agnieszka Łukaszewska – Supervisory Board Member

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2019-10-08.

  • mBank
    56 1140 2004 0000 3502 7793 9709

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$13,972
Other crisis aid
$1,926
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282

FAQ

Last updated: 2026-10-07